Author: Ojosnegros, Samuel; Beerenwinkel, Niko
Title: Models of RNA virus evolution and their roles in vaccine design Document date: 2010_11_3
ID: 0q928h3b_32
Snippet: With one exception, the few attempts to bring HIV vaccines to the last phases of clinical trials have been quite disappointing so far. One of the first and most prominent vaccine candidates, the VAXGEN vaccine, was intended to immunize subjects with a recombinant envelope protein of HIV (rgp120) [93, 94] . The envelope protein is located on the surface of HIV and is responsible for the attachment of the virus to the host cell surface receptor [95.....
Document: With one exception, the few attempts to bring HIV vaccines to the last phases of clinical trials have been quite disappointing so far. One of the first and most prominent vaccine candidates, the VAXGEN vaccine, was intended to immunize subjects with a recombinant envelope protein of HIV (rgp120) [93, 94] . The envelope protein is located on the surface of HIV and is responsible for the attachment of the virus to the host cell surface receptor [95] . Antibodies targeted against this protein could block HIV infection and subsequently block virus entry into cells. During VAXGEN trials, the immunization induced the production of antibodies in vaccinated individuals, but they were unable to control infection or viremia.
Search related documents:
Co phrase search for related documents- HIV infection and vaccine candidate: 1, 2, 3, 4, 5
- HIV surface and vaccine candidate: 1
- HIV surface and virus attachment: 1, 2, 3
- HIV surface and virus entry: 1, 2, 3, 4, 5
- HIV vaccine and protein target: 1, 2
- HIV vaccine and vaccine candidate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- HIV vaccine and viremia infection: 1, 2
- HIV vaccine and virus attachment: 1
- HIV vaccine and virus entry: 1
- protein target and vaccine candidate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- protein target and virus attachment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- protein target and virus entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58
- protein target and virus entry block: 1, 2, 3
- vaccine candidate and viremia infection: 1
- vaccine candidate and virus attachment: 1, 2, 3, 4, 5
- vaccine candidate and virus entry: 1, 2, 3, 4, 5, 6, 7, 8, 9
- vaccine candidate and virus entry block: 1, 2
- viremia infection and virus entry: 1
Co phrase search for related documents, hyperlinks ordered by date